Diabetes News and Research

Latest Diabetes News and Research

Palatin confirms initiation of AZD2820 Phase 1 trial in obesity

Palatin Technologies, Inc. confirmed today the commencement of a Phase 1 clinical trial of AZD2820, a subcutaneously-administered peptide melanocortin receptor partial agonist, under development as a single-agent therapy for the treatment of obesity.

4 Aug 2011

Boston Therapeutics files chewable metformin ANDA with FDA to treat diabetes

Boston Therapeutics, Inc., a public company registered with the SEC and a developer of diabetes therapeutics, today announced that it has submitted an Abbreviated New Drug Application (ANDA) for chewable metformin with the U.S. Food and Drug Administration.

4 Aug 2011

UH undergraduates seek solutions to many maladies like diabetes, Alzheimer's

Students from a variety of majors are devoting their summers to serious research at the University of Houston (UH), seeking eventual solutions to many serious maladies that include Alzheimer's, high blood pressure and cholesterol, diabetes, alcoholism and anxiety.

4 Aug 2011

Breastfeeding for up to one year after birth can reduce child mortality, UNICEF says

Breastfeeding from birth to six months or a year can reduce deaths among children under five by 13 percent, a fact UNICEF is highlighting during World Breastfeeding Week, which runs through August 7, the International Business Times reports.

4 Aug 2011

Study reveals link between increased spirit consumption and acute pancreatitis

Drinking just one 4cl measure of spirits can increase the risk of an acute attack of pancreatitis, but wine or beer does not appear to have the same effect, according to a study published online by BJS, the British Journal of Surgery.

4 Aug 2011

Pharming, Santarus reach SPA agreement with FDA for RHUCIN Phase III trial

Specialty biopharmaceutical company Santarus, Inc. and biotech company Pharming Group NV today announced that they have reached agreement with the U.S. Food and Drug Administration (FDA) on the design of a Phase III clinical study with the investigational drug RHUCIN under the Special Protocol Assessment (SPA) process that is intended to support the submission of a Biologics License Application.

4 Aug 2011

Avaxia receives BARDA contract to develop new radiation mitigation drug

Avaxia Biologics, Inc., a privately-held biotech company developing oral antibody drugs that act locally within the gastrointestinal tract, announced today it was awarded a contract with the Biomedical Advanced Research and Development Authority (BARDA), for the research and development of an oral antibody therapy to mitigate the gastrointestinal damage that follows radiation exposure that might occur after a nuclear incident.

4 Aug 2011

W.M. Keck Foundation awards Jefferson scientists with $1M medical research grant

Scientists at Thomas Jefferson University have been awarded a $1 million medical research grant from the W.M. Keck Foundation for an ambitious project looking at the little explored 98 percent of the human genome and what role it may play in the onset and progression of diseases.

4 Aug 2011

Different health care delivery systems offer differing visions of efficiency

One California partnership that involved a large insurance company, a major hospital chain and a group of doctors has reduced health care costs. But a new report shows that the growing number of hospital-based physicians may ultimately be taxing Medicare resources.

3 Aug 2011

AACE's five-tiered approach to elimination of endocrine healthcare disparities

The American Association of Clinical Endocrinologists (AACE) today is announcing the adoption of a new policy reaffirming the Association's commitment to the elimination of endocrine healthcare disparities in the United States.

3 Aug 2011

UTHealth student receives UNCF/Merck fellowship for multidrug-resistant CDI research

Charles Darkoh, a graduate student at The University of Texas Health Science Center at Houston (UTHealth), has been awarded a fellowship from the United Negro College Fund (UNCF) and Merck for his research into a major health problem - multidrug-resistant Clostridium difficile bacterial infection.

3 Aug 2011

Double-lung transplant survivor stays busy since retirement

Fewer than half of lung transplant patients survive for five years. But nearly 14 years after receiving a double-lung transplant at Loyola University Medical Center, Damian Neuberger's lungs continue to function normally. He breathes easily while walking four or five miles a day.

3 Aug 2011

Negative physiological changes may raise risk of type 2 diabetes

According to the Centers for Disease Control and Prevention, 25 percent of Americans have inactive lifestyles and 75 percent do not meet the weekly exercise recommendations to maintain good health.

3 Aug 2011

Lifestyle factors of people with exceptional longevity

People who live to 95 or older are no more virtuous than the rest of us in terms of their diet, exercise routine or smoking and drinking habits, according to researchers at Albert Einstein College of Medicine of Yeshiva University.

3 Aug 2011

New alternative to immunosuppressive treatment after kidney transplants without severe side effects

There is now a new alternative to immunosuppressive treatment after kidney transplants which comes without the usual severe side effects. The Medical University was significantly involved in the clinical development of the active ingredient Belatacept and a suitable preparation has now been given EU-wide authorisation.

3 Aug 2011

Hydrogen sulfide protects blood vessels from diabetes complications

Hydrogen sulfide is a foul-smelling gas with an odor resembling that of rotten eggs. Sometimes called "swamp gas," this toxic substance is generally associated with decaying vegetation, sewers and noxious industrial emissions. And - as odd as it may seem - it also plays a critical role in protecting blood vessels from the complications of diabetes, according to a new study from the University of Texas Medical Branch at Galveston.

3 Aug 2011

New generation antidepressants may increase risk of adverse outcomes in elderly

Older people taking new generation antidepressants are at more risk of dying or suffering from a range of serious health conditions including stroke, falls, fractures and epilepsy, a study involving researchers at The University of Nottingham has found.

3 Aug 2011

New HHS rule requires insurance coverage for contraception, other preventive services for women

The regulations, which were issued Monday by Health and Human Services Secretary Kathleen Sebelius, implement what is likely to be one of the most wide-reaching and popular provisions of the health law.

3 Aug 2011

Hospitals not doing enough to encourage breastfeeding among new mothers: CDC report

According to a report by the U.S. Centers for Disease Control and Prevention (CDC), hospitals are not doing enough to encourage breastfeeding among new mothers.

3 Aug 2011

FDA grants IDE approval for Apnex HGNS System to treat obstructive sleep apnea

Apnex Medical, Inc., received investigational device exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to begin a clinical study to evaluate the safety and effectiveness of its Hypoglossal Nerve Stimulation System to treat obstructive sleep apnea.

3 Aug 2011